← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bolden Therapeutics, Inc.
Providence, RI
$2,305,435
Total funding
4
Grants
Funding over time
peak $904K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,305,435 · 4
By mechanism
R43$1,408,521 · 3
R41$896,914 · 1
Investigators at Bolden Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Preclinical characterization of splice-modifying antisense oligonucleotides targeting neurogenesis in human AD neural cells$504,505
R43 · FY2024 · AG
Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy$500,000
R41 · FY2021 · AG
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy$497,550
R43 · FY2022 · AG
Entrepreneurial development award for a novel Alzheimer's disease therapeutic$406,466
R43 · FY2022 · AG
Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy$396,914
R41 · FY2023 · AG